199 related articles for article (PubMed ID: 24829397)
1. Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.
Wali VB; Haskins JW; Gilmore-Hebert M; Platt JT; Liu Z; Stern DF
Mol Cancer Res; 2014 Aug; 12(8):1140-55. PubMed ID: 24829397
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
[TBL] [Abstract][Full Text] [Related]
3. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
Haskins JW; Nguyen DX; Stern DF
Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
[TBL] [Abstract][Full Text] [Related]
4. Cell death or survival promoted by alternative isoforms of ErbB4.
Sundvall M; Veikkolainen V; Kurppa K; Salah Z; Tvorogov D; van Zoelen EJ; Aqeilan R; Elenius K
Mol Biol Cell; 2010 Dec; 21(23):4275-86. PubMed ID: 20943952
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the four isoforms of receptor tyrosine kinase ErbB4, but not ErbB1, confers cardiomyocyte hypertrophy.
Wang Z; Chan HW; Gambarotta G; Smith NJ; Purdue BW; Pennisi DJ; Porrello ER; O'Brien SL; Reichelt ME; Thomas WG; Paravicini TM
J Cell Physiol; 2021 Dec; 236(12):8160-8170. PubMed ID: 34170016
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
[TBL] [Abstract][Full Text] [Related]
7. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.
Muraoka-Cook RS; Feng SM; Strunk KE; Earp HS
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):235-46. PubMed ID: 18437540
[TBL] [Abstract][Full Text] [Related]
8. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
Määttä JA; Sundvall M; Junttila TT; Peri L; Laine VJ; Isola J; Egeblad M; Elenius K
Mol Biol Cell; 2006 Jan; 17(1):67-79. PubMed ID: 16251361
[TBL] [Abstract][Full Text] [Related]
10. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
Bae JA; Kho DH; Sun EG; Ko YS; Yoon S; Lee KH; Ahn KY; Lee JH; Joo YE; Chung IJ; Lee SH; Kim H; Kim KK
Clin Cancer Res; 2016 Mar; 22(5):1284-94. PubMed ID: 26527747
[TBL] [Abstract][Full Text] [Related]
11. Developmental, neurochemical, and behavioral analyses of ErbB4 Cyt-1 knockout mice.
Erben L; Welday JP; Cronin ME; Murphy R; Skirzewski M; Vullhorst D; Carroll SL; Buonanno A
J Neurochem; 2022 Jun; 161(5):435-452. PubMed ID: 35523590
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of the human ErbB4 gene: identification of novel splice isoforms in the developing and adult brain.
Tan W; Dean M; Law AJ
PLoS One; 2010 Sep; 5(9):e12924. PubMed ID: 20886074
[TBL] [Abstract][Full Text] [Related]
13. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.
Muraoka-Cook RS; Sandahl M; Husted C; Hunter D; Miraglia L; Feng SM; Elenius K; Earp HS
Mol Biol Cell; 2006 Sep; 17(9):4118-29. PubMed ID: 16837552
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin-3 regulates epithelial progenitor cell positioning and specifies mammary phenotype.
Kogata N; Oliemuller E; Wansbury O; Howard BA
Stem Cells Dev; 2014 Nov; 23(22):2758-70. PubMed ID: 24936779
[TBL] [Abstract][Full Text] [Related]
15. Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells.
Zeng F; Xu J; Harris RC
FASEB J; 2009 Jun; 23(6):1935-45. PubMed ID: 19193720
[TBL] [Abstract][Full Text] [Related]
16. A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution.
Erben L; He MX; Laeremans A; Park E; Buonanno A
Mol Neurobiol; 2018 Jul; 55(7):6169-6181. PubMed ID: 29264769
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.
Sudol M
Sci Signal; 2014 Dec; 7(355):pe29. PubMed ID: 25492964
[TBL] [Abstract][Full Text] [Related]
18. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.
Kainulainen V; Sundvall M; Määttä JA; Santiestevan E; Klagsbrun M; Elenius K
J Biol Chem; 2000 Mar; 275(12):8641-9. PubMed ID: 10722704
[TBL] [Abstract][Full Text] [Related]
19. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.
Zeng F; Zhang MZ; Singh AB; Zent R; Harris RC
Mol Biol Cell; 2007 Nov; 18(11):4446-56. PubMed ID: 17761534
[TBL] [Abstract][Full Text] [Related]
20. Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants.
Junttila TT; Sundvall M; Määttä JA; Elenius K
Trends Cardiovasc Med; 2000 Oct; 10(7):304-10. PubMed ID: 11343971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
